Benicar Lawsuit | Side Effects : Gastrointestinal Problems, Chronic Diarrhea, Eteropathy, Weight Loss, Celiac Disease

Benicar Lawsuit | Side Effects : Gastrointestinal Problems, Chronic Diarrhea, Eteropathy, Weight Loss, Celiac Disease

Benicar Lawsuits, Benicar Side Effects, Benicar intestinal problems, Benicar Gastrointestinal Problems, Benicar Chronic Diarrhea, Benicar Eteropathy, Benicar Weight Loss, Benicar Celiac Disease

benicar-lawsuit-side-effects-gastrointestinal-problems-chronic-diarrhea-eteropathy-weight-loss-celiac-disease-2Benicar patients may be entitled to compensation if they experienced severe intestinal problems while using this blood pressure medication. According to a recent warning from the U.S. Food & Drug Administration (FDA), patients treated with Benicar could be in danger of developing sprue-like enteropathy, a serious gastrointestinal condition that mimics celiac disease. Symptoms of Benicar-induced sprue-like enteropathy include:

  • Chronic diarrhea
  • Severe, rapid weight loss
  • Dehydration
  • Vomiting
  • Inflammation of the intestines

FDA-LogoSince the FDA issued its alert, a number of Benicar lawsuits have been filed on behalf of patients who allegedly suffered severe and chronic gastrointestinal problems due to their use of the medication. Wright & Schulte LLC is investigating a number of similar claims, and would like to hear from any Benicar user who experienced serious digestive issues that may be related to the drug. Our Benicar lawyers might be able to help you obtain compensation for any damages you sustained due to this complication, including medical bills and lost wages, permanent disability, and pain and suffering. To learn more, please contact Wright & Schulte LLC as soon possible for a free, no obligation Benicar lawsuit consultation to ensure you are treated fairly and receive all of the compensation the law allows.

Status of Benicar Lawsuits (Olmesartan medoxomil)

benicar-lawsuit-side-effects-gastrointestinal-problems-chronic-diarrhea-eteropathy-weight-loss-celiac-diseaseDaiichi Sankyo, the manufacturer of Benicar released the hypertension drug on the market in 2002, but in July of 2013 the FDA issued a warning that Benicar can cause sprue-like enteropathy. Some of first lawsuits filed against Daiichi Sankyo were in New Jersey state court in February 2014. Judges then moved the cases to federal court.

A recent Benicar lawsuit was filed on behalf of a Texas man who developed sprue-like enteropathy, a rare gastrointestinal disease after using the popular blood pressure medication. Sprue-like enteropathy is a rare condition that causes severe gastrointestinal symptoms and is often mistaken as Celiac disease, a disease that occurs when the body cannot process gluten. Symptoms of Sprue-like enteropathy include chronic diarrhea and rapid weight loss.

People who take Benicar and suffer from digestive issues may not realize the drug is to blame since the severe chronic diarrhea caused by the drug can be mistaken for other diseases like Celiac disease or other intestinal issues.

In a Law360 article one attorney said, “There will be quite a few of these springing up around the nation. Whether that’s in the hundreds or thousands remains to be seen.”

Benicar Gastrointestinal Problems

benicar-sprue-like-enteropathy-side-effectBenicar, known generically as olmesartan, is marketed by Daiichi Sankyo, which spent approximately $1 billion between 2002 and 2008 to promote Benicar and Benicar HCT. Among other things, the company claimed that Benicar was safer and more effective than other angiotensin receptor blockers (ARB) on the market.
Ten years after Benicar was launched on the market, a study published by Mayo Clinic Proceeding reported that a number of patients using the medication had developed gastrointestinal problems similar to those associated with celiac disease. The symptoms disappeared once the patients had stopped using Benicar, strongly hinting at a link between the problems and the medication.

In 2013, the FDA ordered that the product labels for Benicar and related medications, including Benicar HCT, Azor, and Tribenzor, be updated to include information about a possible association with sprue-like enteropathy, after the agency reviewed “clear evidence of an association between olmesartan” and the disorder. The FDA advised physicians to discontinue Benicar treatment in patients who experience extreme weight loss, chronic diarrhea, or other symptoms indicative of sprue-like enteropathy if no other cause for their problems is found.

What is Sprue-Like Enteropathy?

Sprue-like enteropathy is characterized by a flattening of the villi of the small intestines. Damage to these hair-like structures, which absorb nutrients from food, can lead to a host of problems, including:

  • Vitamin deficiency
  • Malnutrition
  • Rapid weight loss
  • Diarrhea
  • Pain and indigestion
  • Fatty, foul smelling stools (Steatorrhea)

gastrointestinal-problems-chronic-diarrhea-eteropathy-1Over the long-term, Benicar-induced sprue-like enteropathy can lead to villous atrophy, a condition that occurs when the villi decay and erode away. This disorder can permanently reduce the ability of the small intestines to absorb nutrients from food and cause malnourishment and dehydration. In its most severe stage, villous atrophy can cause undigested food particles to pass into the bloodstream, where they can trigger an immune reaction and any number of food sensitivities.

Benicar Lawsuit Consultations

Wright & Schulte LLC is offering free Benicar lawsuit legal consultations to victims of sprue-like enteropathy or other sever gastrointestinal problems linked to Benicar. To learn if you may be eligible to file a Benicar lawsuit, please contact Wright & Schulte LLC today by completing the online form on the right, or call toll free, 1-800-399-0795.

Print